过去一年中添加的文章，按日期排序
Prognostic Value of Weekly Delta-Radiomics during MR-Linac Radiotherapy of Glioblastoma
K Cullison, G Simpson, A Valderrama… - International journal of …, 2023 - redjournal.org
342 天前 - Purpose/Objective (s) MRI after chemoradiotherapy (chemoRT) shows areas of
presumed tumor growth in≤ 50% of glioblastoma (GBM) patients, which can be true
progression (TP)–tumor growth with poor treatment response, or pseudoprogression (PP)–
edema and tumor necrosis with favorable treatment response. Patients with TP have median
overall survival (OS) of only 7 months, while patients with PP have median OS of 36 months.
However, on imaging, TP and PP are usually not discernible during treatment, making it …
presumed tumor growth in≤ 50% of glioblastoma (GBM) patients, which can be true
progression (TP)–tumor growth with poor treatment response, or pseudoprogression (PP)–
edema and tumor necrosis with favorable treatment response. Patients with TP have median
overall survival (OS) of only 7 months, while patients with PP have median OS of 36 months.
However, on imaging, TP and PP are usually not discernible during treatment, making it …